Nalo Therapeutics Inc.
Nalo Therapeutics Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer | EGFR Mutation-Related Tumors | Active, not recruiting | Phase 1 | 2025-03-11 | NCT05514496 |